How to Streamline 340B Reporting for Multi-Clinic Entities
The 340B Drug Pricing Program has grown rapidly, with over 60,000 covered entities as of 2025 and billions in drug discounts. For multi-clinic entities, accurate 340B reporting is critical to remain compliant and maximize savings. This blog explores governance, technology, and compliance strategies, while showing how GATP Solutions helps providers streamline reporting across all sites.
How to Streamline 340B Reporting for Multi-Clinic Entities Read More »




